Question 1

Does Schonfeld Strategic Advisors own ACRS stock?

Accepted Answer

No. Schonfeld Strategic Advisors exited its ACRS (Aclaris Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 127,592 shares worth $195,215.

Question 2

How many shares of ACRS does Schonfeld Strategic Advisors own?

Accepted Answer

None since Q2 2025, when Schonfeld Strategic Advisors exited the position. Its Q1 2025 13F listed 127,592 shares worth $195,215.

Question 3

What is Schonfeld Strategic Advisors' ACRS position worth?

Accepted Answer

Schonfeld Strategic Advisors' ACRS position was worth $195,215 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Schonfeld Strategic Advisors buying or selling ACRS?

Accepted Answer

In Q2 2025, Schonfeld Strategic Advisors exited its entire ACRS position.

Question 5

When did Schonfeld Strategic Advisors first buy ACRS?

Accepted Answer

Schonfeld Strategic Advisors first reported ACRS in its Q1 2020 13F and listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$1.42	0
2025-Q1	Decreased	127,592	-3.3%	$195,215	0.0%	$1.53	0
2024-Q4	New	131,895	—	$327,099	0.0%	$2.48	33
2024-Q3	Exited	0	-100.0%	$0	0.0%	$1.15	0